Related Experiment Video
Updated: May 11, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Refractory coeliac sprue is a diffuse gastrointestinal disease.
V Verkarre1, V Asnafi, T Lecomte
1Department of Pathology and Université René Descartes-Paris V (EA219), AP-HP, Hôpital Necker-Enfants Malades, 75015 Paris, France. virginie.verkarre@nck.ap-hop-paris.fr
Refractory coeliac sprue (RCS) involves abnormal T cells spreading throughout the digestive tract and blood. This suggests RCS is a diffuse gastrointestinal disease, not just confined to the small intestine.
Area of Science:
- Gastroenterology
- Immunology
- Oncology
Background:
- Refractory coeliac sprue (RCS) is characterized by an aberrant clonal intraepithelial lymphocyte (IEL) population, considered a cryptic form of intestinal T cell lymphoma.
- Understanding the distribution of this abnormal IEL population is crucial for diagnosing and managing RCS.
Purpose of the Study:
- To investigate the distribution of the abnormal and monoclonal IEL population throughout the digestive tract in patients with RCS.
- To compare IEL phenotype and T cell clonality in gastric, colonic, and blood samples from RCS patients versus controls.
Main Methods:
- Compared frequency of lymphocytic gastritis (LG) and lymphocytic colitis (LC) in RCS, active coeliac disease (ACD), and gluten-free diet coeliac disease (GFD-CD) patients.
- Utilized immunohistochemistry and T cell receptor gamma gene (TCR-gamma) rearrangement analysis to assess IEL phenotype and clonality.
- Analyzed gastric, colonic, and blood samples from 15 RCS patients, 18 ACD patients, and 10 GFD-CD patients.
Main Results:
- Lymphocytic gastritis (LG) was found in 64% of RCS patients, and lymphocytic colitis (LC) in 55%.
- Aberrant IEL phenotypes were observed in LG and LC samples from RCS patients, unlike in coeliac disease patients.
- Monoclonal TCR-gamma rearrangements were detected in 62% of gastric, 80% of colonic, and 44% of blood samples from RCS patients.
Conclusions:
- The aberrant monoclonal IEL population in RCS disseminates beyond the small intestine to the blood and entire gastrointestinal epithelium.
- RCS should be considered a diffuse gastrointestinal disease due to the widespread nature of the abnormal IEL population.
- Findings highlight the systemic involvement in RCS, impacting diagnosis and treatment strategies.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Other Disorders of Digestive System
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

